On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Benjamin P BrownC M Lovly

Abstract

The third-generation EGFR inhibitor, osimertinib, is the first mutant-selective inhibitor that has received regulatory approval for the treatment of patients with EGFR-mutant lung cancer. Despite the development of highly selective third-generation inhibitors, acquired resistance remains a significant clinical challenge. Recently, we and others have identified a novel osimertinib resistance mutation, G724S, which was not predicted in in vitro screens. Here, we investigate how G724S confers resistance to osimertinib.Experimental Design: We combine structure-based predictive modeling of G724S in combination with the 2 most common EGFR-activating mutations, exon 19 deletion (Ex19Del) and L858R, with in vitro drug-response models and patient genomic profiling. Our simulations suggest that the G724S mutation selectively reduces osimertinib-binding affinity in the context of Ex19Del. Consistent with our simulations, cell lines transduced with Ex19Del/G724S demonstrate resistance to osimertinib, whereas cells transduced with L858R/G724S are sensitive to osimertinib. Subsequent clinical genomic profiling data further suggest G724S occurs with Ex19Del but not L858R. Furthermore, we demonstrate that Ex19Del/G724S retains sensitivity to a...Continue Reading

References

Jul 23, 2004·The Journal of Chemical Physics·Donald HamelbergJ Andrew McCammon
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Jul 3, 2008·The Journal of Physical Chemistry. B·In Suk Joung, Thomas E Cheatham
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Aug 14, 2012·The Journal of Pharmacology and Experimental Therapeutics·Flavio SolcaGuenther R Adolf
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alice T Shaw, Jeffrey A Engelman
Mar 9, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helena A YuGregory J Riely
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Sep 17, 2013·Structure·Yifan SongDavid Baker
Oct 17, 2014·Proceedings of the National Academy of Sciences of the United States of America·Christopher L McClendonSusan S Taylor
May 8, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dalia ErcanPasi A Jänne
Aug 25, 2015·Journal of Chemical Theory and Computation·Yinglong MiaoJ Andrew McCammon
Nov 3, 2015·Journal of Structural Biology·Yuliana YosaatmadjaChristopher J Squire
Sep 11, 2012·Journal of Chemical Theory and Computation·Bill R MillerAdrian E Roitberg
Aug 5, 2016·Biochemistry·Brian J BenderRocco Moretti
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Yinglong Miao, J Andrew McCammon
Jan 27, 2017·Cancer Discovery·Jessica J LinAlice T Shaw
Feb 22, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James Chih-Hsin YangPasi A Jänne
Mar 14, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nir PeledYehiel Elkabetz
Aug 26, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A OztanL E Raez
Aug 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suresh S RamalingamPasi A Jänne
Nov 21, 2017·The New England Journal of Medicine·Jean-Charles SoriaUNKNOWN FLAURA Investigators
Jan 27, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jessica J LinSai-Hong Ignatius Ou
Jan 1, 2017·Annual Reports in Computational Chemistry·Yinglong Miao, J Andrew McCammon
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S S RamalingamJ Gray
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V A PapadimitrakopoulouT S K Mok

❮ Previous
Next ❯

Citations

Nov 30, 2019·Journal of Cellular and Molecular Medicine·Chang YuXiaoying Huang
Sep 17, 2020·International Journal of Molecular Sciences·Marcus ConradHeinrich Sticht
Jun 20, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J Piper-VallilloZofia Piotrowska
Oct 1, 2019·British Journal of Cancer·Alessandro LeonettiMarcello Tiseo
Jun 12, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anna TruiniKaterina Politi
Mar 21, 2020·Cancer Research·Jacqueline H StarrettKaterina Politi
Jan 9, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam J SchoenfeldHelena A Yu
Oct 3, 2020·Cancer Discovery·Emiliano CoccoMaurizio Scaltriti
Jul 31, 2020·Seminars in Cancer Biology·Soo-Ryum YangReinhard Büttner
Oct 14, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helena A YuDavid Planchard
Feb 18, 2021·Expert Opinion on Pharmacotherapy·Luigi CerboneCarlo Genova
Feb 26, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Wenfeng FangLi Zhang
Apr 4, 2020·Cell·Jeremy GoecksJoe W Gray
Oct 17, 2020·Oncogene·Hannah L TumbrinkMartin L Sos
May 11, 2021·Molecular Oncology·Martyna Filipska, Rafael Rosell
Jun 30, 2021·The Kaohsiung Journal of Medical Sciences·Tai-Huang Lee, Chih-Jen Yang
Mar 7, 2021·Anti-cancer Drugs·Roberta MinariMarcello Tiseo
Aug 16, 2019·Journal of Medicinal Chemistry·Janina NiggenaberDaniel Rauh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.